Spots Global Cancer Trial Database for interferon gamma
Every month we try and update this database with for interferon gamma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
The 1st Tumor CytokinoTherapy Database (TCTD-1) | NCT06222801 | Oncology | Tumor necrosis ... Interferon gamm... | 18 Years - 95 Years | OncoCareClinic 308 Ltd | |
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH | NCT03985423 | Hemophagocytic ... | Emapalumab-Lzsg | 18 Years - | Swedish Orphan Biovitrum | |
Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts | NCT05156541 | Human Papilloma... Anogenital Wart... | Interferon gamm... | 18 Years - 50 Years | SPP Pharmaclon Ltd. | |
The 1st Tumor CytokinoTherapy Database (TCTD-1) | NCT06222801 | Oncology | Tumor necrosis ... Interferon gamm... | 18 Years - 95 Years | OncoCareClinic 308 Ltd | |
HGS-ETR2 to Treat Children With Solid Tumors | NCT00428272 | Ewing's Sarcoma Osteosarcoma Neuroblastoma Rhabdomyosarcom... | Lexatumumab alo... Lexatumumab in ... Interferon gamm... Gamma 1b potent... | 1 Year - 30 Years | National Institutes of Health Clinical Center (CC) | |
DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors | NCT02197169 | Glioblastoma or... | Single intratum... Interferon-gamm... | 18 Years - | DNAtrix, Inc. | |
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | NCT00501644 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Carboplatin GM-CSF (Sargram... Interferon Gamm... | - | M.D. Anderson Cancer Center | |
Study to Evaluate Interferon Gamma (IFNγ) and Other Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis (M-HLH) | NCT03259230 | Hemophagocytic ... | Blood Draws Data Collection | - | Light Chain Bioscience - Novimmune SA | |
Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma | NCT00977145 | Melanoma | A combination o... | 18 Years - | University of Virginia | |
Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer | NCT00047632 | Ovarian Carcino... Peritoneal Carc... | Interferon gamm... | - | InterMune | |
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH | NCT03985423 | Hemophagocytic ... | Emapalumab-Lzsg | 18 Years - | Swedish Orphan Biovitrum | |
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | NCT00501644 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Carboplatin GM-CSF (Sargram... Interferon Gamm... | - | M.D. Anderson Cancer Center | |
The 1st Tumor CytokinoTherapy Database (TCTD-1) | NCT06222801 | Oncology | Tumor necrosis ... Interferon gamm... | 18 Years - 95 Years | OncoCareClinic 308 Ltd |